RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2350-2356

  Wang, Hongjun ^a   Jiang, Chuanlu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Migration; RAB38; Survival

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; MICRORNA; RAB PROTEIN; RAB38 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CELL MIGRATION; CHINESE; COHORT ANALYSIS; CORRELATION ANALYSIS; DATA BASE; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ADULT; BRAIN NEOPLASMS; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HERMANSKI-PUDLAK SYNDROME; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RAB GTP-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885070612     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2730     Document Type: Article

References (21)

1. Osanai K and Voelker DR: Analysis and expression of Rab38 in oculocutaneous lung disease. Methods Enzymol 438: 203-215, 2008.
2. Yan W, Zhang W, You G, et al: Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol 14: 1432-1440, 2012.
3. Bao Z, Zhang C, Yan W, et al: BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas. J Transl Med 11: 100, 2013.
4. Recchi C and Seabra MC: Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochem Soc Trans 40: 1398-1403, 2012.
5. He H, Dai F, Yu L, et al: Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expr 10: 231-242, 2002.
6. Shimada K, Uzawa K, Kato M, et al: Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92: 1915-1921, 2005.
7. Culine S, Honore N, Closson V, et al: A small GTP-binding protein is frequently overexpressed in peripheral blood mononuclear cells from patients with solid tumours. Eur J Cancer 30A: 670-674, 1994.
8. Yao R, Wang Y, Lubet RA and You M: Differentially expressed genes associated with mouse lung tumor progression. Oncogene 21: 5814-5821, 2002.
9. Liu Y, Zhou Y and Zhu K: Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One 7: e45910, 2012.
10. Overmeyer JH, Young AM, Bhanot H and Maltese WA: A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells. Mol Cancer 10: 69, 2011.
11. Verhaak RG, Hoadley KA, Purdom E, et al: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110, 2010.
12. Gravendeel LA, Kouwenhoven MC, Gevaert O, et al: Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 69: 9065-9072, 2009.
13. Hanzelmann S, Castelo R and Guinney J: GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 14: 7, 2013.
14. R: Core Team: A language and enviroment for statistical computing. http://www.R-project.org. R Foundation for Statistical Conputing 2012, Vienna, Austria.
15. Senft C, Priester M, Polacin M, et al: Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101: 393-403, 2011.
16. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
17. Wang Y, Chen L, Bao Z, et al: Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. Oncol Rep 26: 1173-1180, 2011.
18. Stenmark H and Olkkonen VM: The Rab GTPase family. Genome Biol 2: Reviews 3007, 2001.
19. Barr FA: Rab GTPase function in Golgi trafficking. Semin Cell Dev Biol 20: 780-783, 2009.
20. Subramani D and Alahari SK: Integrin-mediated function of Rab GTPases in cancer progression. Mol Cancer 9: 312, 2010.
21. Ninkovic I, White JG, Rangel-Filho A and Datta YH: The role of Rab38 in platelet dense granule defects. J Thromb Haemost 6: 2143-2151, 2008.